MARISSA VARTAK: Open Payments
NPI 1821537945 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 52 payments from 12 companies in 2025. Trend: 2023 $1,058 · 2024 $935 · 2025 $939
Food & beverage: $929Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $252 |
| Novo Nordisk Inc | 12 | $167 |
| Axsome Therapeutics, Inc. | 3 | $134 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $44 |
| PFIZER INC. | 2 | $34 |
| Grifols USA, LLC | 1 | $30 |
| Biogen, Inc. | 1 | $23 |
Products named: VRAYLAR, Auvelity, Ozempic, CAPLYTA, Wegovy, BREZTRI, VOQUEZNA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
